53 /100
MEDIUM RISK
Score updated Feb 27, 2026
LXEO
Lexeo Therapeutics, Inc.

DilutionScore™ measures dilution risk across 5 factors. Lower scores indicate higher risk of share dilution.

🔔 Get alerts when LXEO's score changes →
📊 Score Breakdown
📋 Offering Ability
40
💰 Cash Runway
75
📊 Float Risk
70
⚠️ Warrant Exposure
85
🔄Convertible Debt
💹 Market Data
Market Cap$524.05M
Shares Outstanding72.99M
Float45.97M
Cash$122.76M
Debt$8.46M
Short InterestN/A
🏛 Institutional Holdings
109 institutional holders · 49.47M shares
#1 JANUS HENDERSON GROUP PLC 6.11M shares
#2 Frazier Life Sciences Management, L.P. 4.42M shares
#3 Balyasny Asset Management L.P. 3.91M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest11.46M
Days to Cover6.8
% of Float24.9%
FINRA data as of Jan 15, 2026
📁 Recent SEC Activity
xbrl XBRL CONVERTIBLE Dec 31, 2023
Full SEC filing analysis available with free account
📰 Recent News
Track LXEO Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking LXEO — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required